ArticleJournal of medicinal chemistry2024

Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant.

Mohammed Monsoor Shaik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.